my.chemie.de
With an accout for my.chemie.de you can always see everything at a glance – and you can configure your own website and individual newsletter.
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH
Christian Matek, born in 1986, received undergraduate degrees in both Physics and Medicine in Munich. He then moved to the UK and finished his DPhil in Theoretical Physics at Oxford University in 2014. Since 2017, his main research interest has been applying artificial intelligence and machine learning techniques in medical diagnostics. In 2020, Christian Matek finished a medical doctorate in that field in a joint project of the Helmholtz Zentrum München and the Department of Medicine III at the University Hospital of the Ludwig-Maximilians-Universität (LMU) München, Munich.
Activities
Christian Matek is currently a postdoctoral researcher at the Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
Awards
The project was supported by the German José Carreras Leukaemia Foundation (Deutsche José Carreras Leukämie-Stiftung) and the German Research Foundation (DFG) through SFB 1243.
Focus
Christian Matek’s research interests focus on applying novel computational methods to medical diagnostics, currently mainly in the diagnosis of leukemia.
Methods
For a long time, doctors have been diagnosing disorders of the body’s hematopoietic system using a light microscope. The analysis of individual blood cells is largely performed manually. (…)
The oat genome unlocks the unique health benefits of oats
Researchers have succeeded in sequencing and characterizing the entire genome of oat. Compared to other cereals and humans, the oat genome architecture is very complex. Scientists from Helmholtz Munich, Lund University and the ScanOats network finally elucidated at the genetic level why oat ... more
A Speed Limit Could Be a Breakthrough for Stem Cell Therapy
Replacing sick or damaged cells with healthy cells: this is a major goal of regenerative medicine. One of the most promising approaches is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research carried out at Helmholtz Munich and Ludwig-Maximilians ... more
COVID-19: Breakthrough infection can substitute for a third vaccine shot
According to a new study led by Ulrike Protzer, a breakthrough infection after two vaccinations achieves the same protective effect as an additional booster vaccination. According to the study by Helmholtz Munich, LMU and TUM, the decisive factor for immunity is that the immune system has h ... more
Using deep learning to better understand blood disorders
For a long time, doctors have been diagnosing disorders of the body’s hematopoietic system using a light microscope. The analysis of individual blood cells is largely performed manually. Now, artificial intelligence can lend them a digital hand. more
Carsten Marr, born in 1977, received his diploma in general physics from the Technische Universität München in 2002. He wrote his diploma thesis at the Max-Planck-Institute for Quantum Optics, Garching, Germany, and in 2003 visited the Quantum Information and Quantum Optics Theory Group at ... more
The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.
> more about q&more
q&more is supported by:
© 1997-2022 LUMITOS AG, All rights reserved
Authors
